The UK has become the first country in the world to issue a marketing authorization to MSD’s molnupiravir, the first oral therapy for COVID-19, to be known as Lagevrio.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) announced its decision on 4 November, saying the antiviral was safe...








